Management of recurrent viral Hepatitis B and C after liver transplantation

被引：3
|
作者：
Montalbano M. [1 ]
Neff G.W. [1 ]
机构：
[1] University of Cincinnati, Cincinnati, OH 45267-0595
来源：
Current Gastroenterology Reports | 2006年 / 8卷 / 1期
关键词：
Lamivudine; Adefovir; Tenofovir Disoproxil Fumarate; Liver Transplant Recipient; Sustained Viral Response;
D O I：
10.1007/s11894-006-0065-x
中图分类号：
学科分类号：
摘要：
Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contra-indication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment-outcomes for HCV and HBV in the period following liver transplant. Copyright © 2006 by Current Science Inc.
引用
收藏
页码：60 / 66
页数：6
相关论文
共 50 条
  • [1] Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation
    Cholongitas, Evangelos
    Papatheodoridis, George V.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (48) : 9189 - 9197
  • [2] Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation
    Evangelos Cholongitas
    George V Papatheodoridis
    World Journal of Gastroenterology, 2013, (48) : 9189 - 9197
  • [3] Hepatitis B and liver transplantation: Update in management before and after transplantation
    Chang M.S.
    Brown Jr. R.S.
    Current Hepatitis Reports, 2011, 10 (4) : 255 - 261
  • [4] Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation
    Laryea, Marie A.
    Watt, Kymberly D.
    LIVER TRANSPLANTATION, 2012, 18 (05) : 514 - 523
  • [5] Prophylaxis against recurrent hepatitis B virus infection after liver transplantation
    Curry M.P.
    Afdhal N.H.
    Current Hepatitis Reports, 2007, 6 (1) : 30 - 34
  • [6] Update on management of hepatitis B before and after liver transplantation
    Surti B.
    Chi A.C.
    Saab S.
    Current Hepatitis Reports, 2008, 7 (1) : 25 - 32
  • [7] Current management of hepatitis B virus infection before and after liver transplantation
    Papatheodoridis, George V.
    Cholongitas, Evangelos
    Archimandritis, Athanasios J.
    Burroughs, Andrew K.
    LIVER INTERNATIONAL, 2009, 29 (09) : 1294 - 1306
  • [8] Viral persistence after liver transplantation for hepatitis B virus: A cross-sectional study
    Freshwater, Dennis A.
    Dudley, Tracey
    Cane, Patricia
    Mutimer, David J.
    TRANSPLANTATION, 2008, 85 (08) : 1105 - 1111
  • [9] Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation
    Utsumi, Masashi
    Takaki, Akinobu
    Umeda, Yuzo
    Koike, Kazuko
    Napier, Stephanie C.
    Watanabe, Nobukazu
    Sadamori, Hiroshi
    Shinoura, Susumu
    Yoshida, Ryuichi
    Nobuoka, Daisuke
    Yasunaka, Tetsuya
    Nakayama, Eiichi
    Yamamoto, Kazuhide
    Fujiwara, Toshiyoshi
    Yagi, Takahito
    TRANSPLANT IMMUNOLOGY, 2014, 31 (01) : 33 - 41
  • [10] Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation
    Herrero, JI
    Quiroga, J
    Sangro, B
    Sola, I
    Riezu-Boj, JI
    Pardo, F
    Prieto, J
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) : 1186 - 1189
12345